Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 1 3Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Hodgkin Disease 24Lymphoma 18Testicular Neoplasms 4Teratoma 3Recurrence 3Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3HIV Infections 3Vulvar Neoplasms 2Testicular Germ Cell Tumor 2Seminoma 2Neoplasms, Germ Cell and Embryonal 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Head and Neck Neoplasms 2Endodermal Sinus Tumor 2Dendritic Cell Sarcoma, Interdigitating 2Carcinoma, Embryonal 2Burkitt Lymphoma 2Acquired Immunodeficiency Syndrome 2Waldenstrom Macroglobulinemia 1Ulcer 1Squamous Cell Carcinoma of Head and Neck 1Sertoli-Leydig Cell Tumor 1Sarcoma, Kaposi 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pathologic Processes 1Ovarian gynandroblastoma 1

Interventions

Valganciclovir 3Paclitaxel 3Nelfinavir 3Bevacizumab 3pembrolizumab 2Zidovudine 2Semaxinib 2Ritonavir 2Propranolol 2Nivolumab 2Interferon alpha-2 2Indinavir 2Filgrastim 2Etoposide 2Doxorubicin 2vesnarinone 1tocilizumab 1tin etiopurpurin 1technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 1talimogene laherparepvec 1nirogacestat 1liposomal doxorubicin 1lenvatinib 1ixazomib 1halofuginone 1etoposide phosphate 1daromun 1Vincristine 1Sunitinib 1Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Sarcoma, Kaposi × Bleomycin × Clear all
NCT00001059 2012-04-17

Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 2 Completed
120 enrolled
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡